Skip to content

Outcome study of hormonal therapy for prostate cancer in Japan

Outcome study of hormonal therapy for prostate cancer in Japan - Outcome study of hormonal therapy for prostate cancer in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-C000000252
Enrollment
24000
Registered
2005-09-29
Start date
2001-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Sponsors

J-CaP study group
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients who were newly stated hormone therapy on prostate cancer after January 2001 to December 2003

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Failure free survival

Countries

Japan

Contacts

Public ContactHideyuki Akaza MD

University of Tsukuba Department of Urology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026